Mouse models of atherosclerosis

Drug Discovery Today: Disease Models

Volumn 4, Issue 4, 2007, Pages 165-170

  Potteaux, Stéphane ^a   Ait Oufella, Hafid ^a   Mallat, Ziad ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL MODEL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; C57BL 6 MOUSE; DISEASE MODEL; INHERITANCE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RUPTURE;

EID: 46749106758     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2007.11.005     Document Type: Review

References (64)

1. Ignatowski A.C. Influence of animal food on the organism of rabbits. Izvest. Imper. Voennomed. Akad. St. Petersburg 16 (1908) 154-173
2. Dansky H.M., et al. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4642-4646
3. Smith J.D., et al. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8264-8268
4. Paigen B., et al. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57 (1985) 65-73
5. Paigen B., et al. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 3763-3767
6. Paigen B., et al. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis 64 (1987) 215-221
7. Liao F., et al. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94 (1994) 877-884
8. Shi W., et al. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102 (2000) 75-81
9. Idel S., et al. A20, a regulator of NFkappaB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14235-14240
10. Vergnes L., et al. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 278 (2003) 42774-42784
11. Mallat Z., et al. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85 (1999) e17-e24
12. Pinderski Oslund L.J., et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2847-2853
13. Potteaux S., et al. In vivo electrotransfer of interleukin-10 cDNA prevents endothelial upregulation of activated NF-kappaB and adhesion molecules following an atherogenic diet. Eur. Cytokine Netw. 17 (2006) 13-18
14. Caligiuri G., et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9 (2003) 10-17
15. Sehayek E., et al. Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: studies in C57BL/6 apolipoprotein E knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3433-3437
16. Linton M.F., et al. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J. Clin. Invest. 101 (1998) 1726-1736
17. Bellosta S., et al. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96 (1995) 2170-2179
18. Thorngate F.E., et al. Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1939-1945
19. Plump A.S., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 (1992) 343-353
20. Zhang S.H., et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 (1992) 468-471
21. Iiyama K., et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85 (1999) 199-207
22. Nakashima Y., et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 842-851
23. Hajra L., et al. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9052-9057
24. Nakashima Y., et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14 (1994) 133-140
25. Reddick R.L., et al. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb. 14 (1994) 141-147
26. Moulton K.S., et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99 (1999) 1726-1732
27. Kawamura A., et al. Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1610-1617
28. Kelly M.E., et al. Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Cell. Immunol. 159 (1994) 124-139
29. Ali K., et al. Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ. Res. 97 (2005) 922-927
30. Brand K., et al. Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J. Clin. Invest. 91 (1993) 2031-2039
31. Duan H., et al. Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression. J. Clin. Invest. 96 (1995) 915-922
32. Grainger D.J. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 399-404
33. Ait-Oufella H., et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115 (2007) 2168-2177
34. Aprahamian T., et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199 (2004) 1121-1131
35. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2255-2264
36. Piedrahita J.A., et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4471-4475
37. Daugherty A., et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J. Clin. Invest. 100 (1997) 1575-1580
38. Song L., et al. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108 (2001) 251-259
39. Hasty A.H., et al. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J. Biol. Chem. 276 (2001) 37402-37408
40. Veniant M.M., et al. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1567-1570
41. Sakai Y., et al. Bone marrow chimerism prevents atherosclerosis in arterial walls of mice deficient in apolipoprotein E. Atherosclerosis 161 (2002) 27-34
42. Potteaux S., et al. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1858-1863
43. Boisvert W.A., et al. Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am. J. Pathol. 168 (2006) 1385-1395
44. Stewart F.A., et al. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am. J. Pathol. 168 (2006) 649-658
45. Desurmont C., et al. Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 435-442
46. Linton M.F., et al. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267 (1995) 1034-1037
47. Trogan E., et al. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3781-3786
48. Jackson C.L., et al. Assessment of unstable atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 714-720
49. Schwartz S.M., et al. Plaque rupture in humans and mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 705-713
50. Johnson J.L., and Jackson C.L. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 154 (2001) 399-406
51. Johnson J., et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 111 (2005) 1422-1430
52. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
53. Calara F., et al. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J. Pathol. 195 (2001) 257-263
54. McAteer M.A., et al. Quantification and 3D reconstruction of atherosclerotic plaque components in apolipoprotein E knockout mice using ex vivo high-resolution MRI. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2384-2390
55. Virmani R., et al. Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 47 8 Suppl. (2006) C13-C18
56. von der Thusen J.H., et al. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 105 (2002) 2064-2070
57. Sasaki T., et al. A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1304-1309
58. da Cunha V., et al. Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis. J. Vasc. Surg. 44 (2006) 364-371
59. Smith D.A., et al. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104 (2001) 746-749
60. Blankenberg S., et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 108 (2003) 2453-2459
61. Heeschen C., et al. Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med. 348 (2003) 1104-1111
62. Mach F., et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394 (1998) 200-203
63. Lutgens E., et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7464-7469
64. Mallat Z., et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ. Res. 89 (2001) E41-E45